Mihaela Bataneant

Dr. Mihaela Bataneant


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
MBMihaela Bataneant
Mihaela Bataneant
CZCristian G. Zimbru
Cristian G. Zimbru
BDBogdan Dragulescu
Bogdan Dragulescu
CMCatalin Vasile Munteanu
Catalin Vasile Munteanu
ACAdela Chirita-Emandi
Adela Chirita-Emandi
Inborn errors of immunity (IEI) are monogenic disorders with a wide spectrum of clinical phenotypes including immune dysregulation, autoimmunity, autoinflammation, and malignancy. IEI may have life-threatening consequences, thus precise and timely genetic diagnosis is crucial for improved access to treatment, genetic counselling and prevention. We aimed to investigate the genotypic findings in a cohort of children with IEI from Romania, in order to understand the diagnostic yield of genetic testing, genetic characterization of IEI and impact of genetic diagnosis. Clinical and genetic investigations were performed in 92 children (50% boys) with IEI phenotype, evaluated between 2018 and 2024, in a tertiary reference genetic center in Timisoara, Romania. Sanger sequencing, next generation sequencing panels with genes associated with IEI (1–474 genes), WES and WGS were used. Disease-causing variants for IEI (pathogenic/likely pathogenic) were identified in 37/92 (40.2%) participants, in 25 genes. 14/92 (15.2%) participants had relevant variants of uncertain significance. Median age at genetic testing was 4.38 (IQR 2–12.8) years. 15/37 (40.5%) of patients with Disease-causing variants had a family history of IEI. NGS gene panels were used in 43/92 (46.7%) patients, WES in 29 (31.5%), while WGS in 20 (21.7%). Twelve patients had more than one genetic test. Most frequent genes with Disease-causing variants identified were: JAGN1(5 patients) and AIRE(3). A great variety of genes were identified as causative for IEI. Considering the highly variable and unspecific phenotype, together with no family history in most cases, prioritizing genetic investigations offers the best option for timely diagnosis and treatment.

4 February 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
DMDavid Mitel Matea
David Mitel Matea
RIRaluca Isac
Raluca Isac
EBEstera Boeriu
Estera Boeriu
PUPatricia Urtila
Patricia Urtila
GDGabriela Doros
Gabriela Doros
SASmaranda Teodora Arghirescu
Smaranda Teodora Arghirescu
Reactive infectious mucocutaneous eruption (RIME) is a rare pediatric condition characterized by severe mucositis, minimal cutaneous involvement, and an infectious rather than drug-induced etiology. Mycoplasma pneumoniae (M. Pneumoniae) represents the most frequently identified trigger, although an increasing number of alternative pathogens have been reported. Its clinical overlap with Stevens–Johnson syndrome (SJS) makes early recognition difficult. We reviewed literature data on the topic and described our center’s experience with three pediatric cases of M. pneumoniae-associated RIME. Medical records, laboratory results, and imaging were systematically analyzed. All patients were male, aged 2 to 12 years and originated from rural communities. Etiologic confirmation was achieved via M. pneumoniae IgM serology and/or polymerase chain reaction. Clinical exam modifications included multi-site mucositis (oral, ocular, genital) with variable skin involvement: absent in one case, a solitary palm ulcer in another, and widespread rash in the third. One patient required two hospitalizations within a six-month interval, confirming the possible relapsing phenotype of RIME. Another patient developed pneumonia, sepsis, and systemic inflammation. All received macrolide therapy, antifungals, mucosal supportive care, and systemic management as indicated. Recovery occurred within 10–21 days, with one patient exhibiting skin hyperpigmentation. These cases illustrate the heterogeneity of RIME, emphasize the importance of prompt recognition, etiology confirmation, and multidisciplinary management. RIME is a rare clinical condition in pediatric population, an uncommon but significant mucocutaneous clinical entity, important to be acknowledged by clinicians as a complication and/or extra-pulmonary manifestation of M. pneumoniae infection.

29 October 2023 in Genes
Verified
Journal Article
Open access
PDF file
Gheorghe-Emilian OlteanuGheorghe-Emilian Olteanu
Gheorghe-Emilian Olteanu
MBMihaela Bataneant
Mihaela Bataneant
MPMaria Puiu
Maria Puiu
ACAdela Chirita-Emandi
Adela Chirita-Emandi
Neonatal diffuse cutaneous mastocytosis (NDCM) is defined as the infiltration of the epidermis by a clonal proliferation of mast cells, observed at birth, without initial signs of systemic involvement. The typical driver mutation is in the KIT gene. We report a rare case of a boy, born at term, already presenting at birth with generalized subcutaneous nodules on the face, scalp, trunk, back, hands, and feet. The spleen, liver, and inflammatory markers were normal at birth. Tryptase was significantly elevated. A bone marrow biopsy showed no mast cell involvement at age 2 months. A punch biopsy at age 2 months revealed CD117-positive cells diffusely infiltrating the skin, with subsequent DNA NGS sequencing for the formalin-fixed paraffin embedded tissue (FFPE) identifying the pathogenic NM_000222.3:c.1504_1509dup; p.(Ala502_Tyr503dup) variant in the KIT gene previously associated with cutaneous mastocytosis. At 2 years follow-up, he had splenomegaly and multiple cervical and inguinal adenopathy, while the skin nodules persisted, especially on the scalp with accompanying pruritus. He received oral and local sodium cromoglycate, oral antihistamines, antibiotic cream for skin infection, and iron supplementation; however, compliance to treatment was relatively low. The prognosis is difficult to predict, as he developed systemic involvement, failure to thrive, and mild psychomotor delay. A case aggregation of NDCM reported in the literature was performed to provide a comprehensive overview of this rare pathology, to better understand the prognosis. NDCM is a life-threatening disease with severe complications. Almost half had severe complications, such as mast hepatosplenomegaly, adenopathy, bacterial infections, mast cell leukaemia, and systemic involvement.

Verified
Journal Article
Open access
PDF file
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
MBMihaela Bataneant
Mihaela Bataneant
CJCiprian Jurcut
Ciprian Jurcut
ACAlexis-Virgil Cochino
Alexis-Virgil Cochino
AIAndreea Ioan
Andreea Ioan
ACAdela Chirita-Emandi
Adela Chirita-Emandi
Inborn errors of immunity (IEIs) encompass a heterogeneous group of more than 550 genetic conditions with variable ages of onset. A significant proportion of IEI arises from genetic variants that may not yet be fully elucidated or recorded in existing genomic databases. Molecular diagnoses are achieved in approximately 15–35% of IEI cases, yet in only 9–20% of individuals with predominant antibody deficiencies, particularly in adult cohorts. We aimed to evaluate whole genome sequencing (WGS) diagnostic yield in adults suspected to have IEI. Clinical assessments of the patients were carried out at tertiary medical institutions in Timisoara and Bucharest, Romania. The study cohort included a consecutive series of 21 adult patients (aged 19–60 years) with IEI phenotype, who underwent genetic analysis, using WGS as the first diagnostic approach. A definitive molecular diagnosis was confirmed in only 9.5% (2/21) of the participants, in LRBA and BTK genes. Variants of uncertain significance (VUS) were detected in three patients (13.6%) in TNFRSF13B, COPA, GATA2 genes. For about half of the cohort the onset of the disease was noted in childhood. WGS as a first-line diagnostic strategy in a cohort of adults with IEI yielded a low diagnostic rate. There were significant delays in genetic diagnosis, as half of the cohort experienced childhood-onset symptoms. Results suggest that adult IEI diagnosis remains challenging, necessitating functional studies and longitudinal re-evaluation of genomic data.

1 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Gheorghe-Emilian OlteanuGheorghe-Emilian Olteanu
Gheorghe-Emilian Olteanu
MBMihaela Bataneant
Mihaela Bataneant
MPMaria Puiu
Maria Puiu
ACAdela Chirita-Emandi
Adela Chirita-Emandi
Neonatal diffuse cutaneous mastocytosis (NDCM) is defined as the infiltration of the epidermis by a clonal proliferation of mast cells, observed at birth, without initial signs of systemic involvement. The typical driver mutation is located in the KIT gene. We report a rare case of a boy, born at term, presenting already at birth with generalized subcutaneous nodules, on the face, scalp, trunk, back, hands, and feet. The spleen, liver and inflammatory markers were normal at birth. Tryptase was significantly elevated. Bone marrow biopsy showed no mast cell involvement at age 2 months. A punch biopsy at age 2 months revealed CD117-positive cells diffusely infiltrating the skin, with subsequent DNA NGS sequencing for the formalin fixed paraffin embedded tissue (FFPE) identifying the pathogenic NM_000222.3:c.1504_1509dup; p.(Ala502_Tyr503dup) variant in the KIT gene previously associated with cutaneous mastocytosis. At 2 years follow-up, he had splenomegaly and multiple cervical, and inguinal adenopathy while the skin nodules persisted especially on the scalp with accompanying pruritus. He received oral and local sodium cromoglycate, oral antihistamines, antibiotic cream for skin infection, and iron supplementation, however compliance to treatment was relatively low. The prognosis is difficult to predict, as he developed systemic involvement, failure to thrive and mild psychomotor delay. A case aggregation of NDCM reported in the literature was performed to provide a comprehensive overview of this rare pathology, to better understand the prognosis. NDCM is a life-threatening disease with severe complications. Almost half had severe complications, such as mast hepatosplenomegaly, adenopathy, bacterial infections, mast cell leukaemia, and systemic involvement.

Verified
Journal Article
Open access
PDF file
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
MBMihaela Bataneant
Mihaela Bataneant
CZCristian ZIMBRU
Cristian ZIMBRU
MSMargit Serban
Margit Serban
MPMaria Puiu
Maria Puiu
ACAdela Chirita-Emandi
Adela Chirita-Emandi
More than 30 distinct genetic entities associated with severe congenital neutropenia (SCN) have been described. SCN has a risk of clonal expansion of mutated hematopoietic cells. Jagunal homolog 1 (JAGN1) deficiency has been described as a genetic cause of SCN and is now estimated to account for approximately 10% of all SCN cases. One prevalent variant in patients with JAGN1 deficiency is NM_032492.4:c.63G>T (p.Glu21Asp). The clinical description and disease evolution study of Romanian patients with JAGN1 deficiency caused by the JAGN1 c.63G>T variant were performed together with a literature review of similar cases. The clinical characterization of six Romanian patients and nine additional patients reported in the literature with JAGN1 deficiency caused by the c.63G>T variant (40% female) revealed a wide phenotypic spectrum, including: neutropenia (all), severe infections (80%), developmental delay (13%), dental problems such as stomatitis/periodontitis (66%), and short stature (7%). No patient developed malignancy/leukemia during the follow-up period (15 ± 8.1 years). Most patients (93%) had a homozygous variant and consanguineous background, while one had compound heterozygous JAGN1 variants. The five Romanian patients carrying this homozygous variant, possibly due to a founder effect, had a relatively favorable clinical outcome, with good overall prognosis.